Business Description
Teleflex Inc
NAICS : 339112
SIC : 3841
ISIN : US8793691069
Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 3.55 | |||||
| Interest Coverage | 6.8 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.57 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | -20 | |||||
| 3-Year EPS without NRI Growth Rate | 1.7 | |||||
| 3-Year FCF Growth Rate | -4 | |||||
| 3-Year Book Growth Rate | 5.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 2.23 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.77 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.38 | |||||
| 9-Day RSI | 56.54 | |||||
| 14-Day RSI | 50.82 | |||||
| 3-1 Month Momentum % | -12.85 | |||||
| 6-1 Month Momentum % | -31.3 | |||||
| 12-1 Month Momentum % | -42.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.28 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 0.42 | |||||
| Days Inventory | 172.29 | |||||
| Days Sales Outstanding | 55.58 | |||||
| Days Payable | 34.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.12 | |||||
| Dividend Payout Ratio | 0.1 | |||||
| Forward Dividend Yield % | 1.12 | |||||
| 5-Year Yield-on-Cost % | 1.12 | |||||
| 3-Year Average Share Buyback Ratio | 1.2 | |||||
| Shareholder Yield % | 7.47 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.68 | |||||
| Operating Margin % | 17.94 | |||||
| Net Margin % | 4.96 | |||||
| EBITDA Margin % | 18.79 | |||||
| FCF Margin % | 15.94 | |||||
| ROE % | 3.41 | |||||
| ROA % | 2.04 | |||||
| ROIC % | 5.8 | |||||
| 3-Year ROIIC % | 5.54 | |||||
| ROC (Joel Greenblatt) % | 22.07 | |||||
| ROCE % | 4.31 | |||||
| Years of Profitability over Past 10-Year | 10 | |||||
| Moat score | 7 | |||||
| Tariff score | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 38.36 | |||||
| Forward PE Ratio | 9.04 | |||||
| PE Ratio without NRI | 8.87 | |||||
| Shiller PE Ratio | 16.28 | |||||
| Price-to-Owner-Earnings | 20.74 | |||||
| PS Ratio | 1.86 | |||||
| PB Ratio | 1.33 | |||||
| Price-to-Free-Cash-Flow | 11.87 | |||||
| Price-to-Operating-Cash-Flow | 9.5 | |||||
| EV-to-EBIT | 24.53 | |||||
| EV-to-Forward-EBIT | 13.43 | |||||
| EV-to-EBITDA | 12.56 | |||||
| EV-to-Forward-EBITDA | 8.84 | |||||
| EV-to-Revenue | 2.36 | |||||
| EV-to-Forward-Revenue | 2.31 | |||||
| EV-to-FCF | 14.81 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Price-to-Projected-FCF | 0.79 | |||||
| Price-to-Median-PS-Value | 0.39 | |||||
| Earnings Yield (Greenblatt) % | 4.08 | |||||
| FCF Yield % | 8.93 | |||||
| Forward Rate of Return (Yacktman) % | 3.78 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers